AVI BioPharma Inc., of Portland, Ore., appointed Paul Medeiros senior vice president of business development and chief business officer...CytRx Corp., of Los Angeles, named Jaisim Shah chief business officer and senior vice president of business development

subsidiary, which raises awareness of subclinical zinc deficiency and chronic copper toxicity...Alnara Pharmaceuticals Inc., of Cambridge, Mass., promoted Robert Gallotto from senior vice president of operations and corporate development to chief business officer

BrainCells Inc., of San Diego, appointed Philip Jochelson chief medical officer and Jason Levin chief business officer...Dafna Cohen and Yaron Diament were appointed external directors

Infinity Pharmaceuticals Inc., of Cambridge, Mass., promoted Adelene Q. Perkins president and chief business officer...It also appointed Bruce R. Thaw chairman and named James E. Rothman chairman of the scientific advisory board

Concert Pharmaceuticals Inc., of Lexington, Mass., named Steven B. Bernitz senior vice president and chief business officer...It formed its scientific advisory board with the appointments of Dennis Brown, Xandra Breakefield and Richard L. Edelson, and also appointed Johan Skog director of genetics research

David Mitchell senior director of regulatory affairs and quality assurance...and Jay Rheingold vice president of chemistry, manufacturing and controls

Ikonysis, of New Haven, Conn., named Louise Mawhinney senior vice president and chief financial officer...Oxford BioMedica plc, of Oxford, UK, promoted Nick Woolf to chief business officer

It also named Guido Magni to its board and the governance and nominating committee...Affimed Therapeutics AG, of Heidelberg, Germany, appointed Volker Land chief business officer

GeneNews Ltd., of Toronto, elected Harry A. Glorikian and Fran Tuttle to its board...Innate Pharma SA, of Marseille, France, named Hemanshu Shah executive vice president and chief business officer for U.S

The company also established a strategic commercialization and partnership committee consisting of directors Peter D. Kiernan III, Neil W. Flanzraich and Georg Nebgen...Modigene Inc., of Nes-Ziona, Israel, named Marian Gorecki and Steven D. Rubin to its board and appointed Phillip Frost chairman

Hana Biosciences Inc., of South San Francisco, named Christopher Salentine vice president of manufacturing and announced the departure of Fred Vitale as vice president and chief business officer...Indivumed, of Hamburg, Germany, named Harald R. Eistetter managing director and chief business officer

Samaritan Pharmaceuticals Inc., of Las Vegas, named Jack L. Ayala and Robert W. Crane to its board of directors...Trellis Bioscience, of San Francisco, appointed John J. Wulf executive vice president of business operations and chief business officer

Draxis Health Inc., of Montreal, named Dan Brazier president and chief executive officer...Panacos Pharmaceuticals Inc., of Watertown, Mass., named Jane Pritchett Henderson chief financial and business officer

Cytheris SA, of Paris, appointed Richard W. Keatinge chief business officer...Evotec AG, of Hamburg, Germany, named Mario Polywka and Klaus Maleck to its management board

DBV Technologies, of Paris, named Hing Kin Chan chief business officer, Florian Reinaud chief financial officer and Laurent Martin regulatory affairs director

Amira Pharmaceuticals Inc., of San Diego, named Hari Kumar chief business officer...Nitec Pharma AG, of Reinach, Switzerland, appointed Anders Harfstrand CEO and Andrea Buscaglia chief financial officer

Prestwick Pharmaceuticals Inc., of Washington, named Robert S. Radie executive vice president and chief business officer...ProtAffin AG, of Graz, Austria, named Timothy Wells and Marco Sardinia to its scientific advisory board

Avontec GmbH, of Martinsried, Germany, named Helge Grupe as chief business officer and managing director...DBV Technologies, of Boulogne-Billancourt, France, has strengthened its management team with three new appointments and moved into larger premises...and Laurent Martin has been appointed regulatory affairs director

BioLineRx Ltd., of Jerusalem, appointed Tamar Howson, Gil Bianco and Ilan Leviteh to its board of directors...Bradmer Pharmaceuticals Inc., of Toronto, named Alan M. Ezrin chief executive officer and Brian Brohman chief business officer